Middle East Implantable Neurostimulators Market

An Implantable Neurostimulators is surgically placed device which sends mild electric signals to the space near spine. An implantable neurostimulation system has Neurostimulators, leads, physician’s programmer, patient programmer as its components. Neurostimulators provides pain relief by removing the pain signals between spinal cord & brain. These are particularly used for the treatment of various disorders such as movement disorders, epilepsy, Parkinson’s disease, chronic pain, depression, obesity etc.

Rising number of neurological disorders, external funding for R&D, government measures for encouraging the industries & growing demand for minimal invasive surgeries are some factors that are likely to propel the market. Rising geriatric population will also be the factor for the market growth as this segment of population is more prone to neurological disorders like epilepsy, Alzheimer etc. Following by, Development of advanced neurostimulation technologies, Technological advancement in Intrapace closed-loop gastric electrical stimulator for obesity etc are more likely to grow the market. However, hypersensitivity, high cost of Implantable Neurostimulators Market, lack of skilled professionals &unfavorable reimbursement scenario aresome of the factors that may restrain the growth of the market.

Various notable players are Medtronic, St. Jude Medical Inc., Boston Scientific Inc., Aleva Neurotherapeutics SA, Cyberonics, Inc., Dynatronics Corporation, NeuroPace, Synapse Biomedical, NeuroSigma, EnteroMedics

Middle East Implantable Neurostimulators Market has been segmented based on type & application. Based on type, the market comprises ofDeep Brain Stimulators, Spinal Cord Stimulators, Vagal Nerve Stimulators, Sacral Nerve Stimulators, Gastric Stimulators, Others. The research report “Middle East Implantable Neurostimulators Market” provides in-depth analysis of Middle East Implantable Neurostimulators Market based on type & application for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the Middle East Implantable Neurostimulators Market In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1- At what pace Middle East Implantable Neurostimulators Market is growing? What will be growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the Middle East Implantable Neurostimulators Market?
4- What are the various type, source, application areas and how they are poised to grow?

Market Segmentation

By Type
• Deep Brain Stimulators

• Spinal Cord Stimulators
◦ Chronic Pain
◦ Failed Back Surgery Syndrome
◦ Ischemic Pain
◦ Others

• Vagal Nerve Stimulators
◦ Epilepsy
◦ Others

• Sacral Nerve Stimulators
◦ Urinary Incontinence
◦ FacalIncontinence

• Gastric Stimulators
◦ Gastroparesis

• Others

By Application
• Parkinson’s Disease
◦ Tremor
◦ Depression
◦ Others
• Alzheimer
• Pain Management
• Epilepsy
• Dystonia
• Others

Market Players
• Medtronic
• St. Jude Medical Inc.
• Boston Scientific Inc.
• Aleva Neurotherapeutics SA
• Cyberonics, Inc.
• Dynatronics Corporation
• NeuroPace
• Synapse Biomedical
• NeuroSigma
• EnteroMedics